TON - June 2013, Vol 6, No 5

Drug Combination Potentially Effective in BRCA-Deficient Solid Tumors

TON - June 2013, Vol 6, No 5 — July 10, 2013

Two orally available experimental drugs achieved response in patients with BRCA-deficient solid tumors in a phase 1 study of 38 patients. Read More ›

Genetic Analysis Identifies 4 Subsets of Squamous Cell Carcinoma of the Head and Neck

By Alice Goodman

Head and Neck Cancer

TON - June 2013, Vol 6, No 5 — July 10, 2013

Comprehensive genetic analysis by The Cancer Genome Atlas (TCGA) identified 4 different subtypes of squamous cell carcinoma of the head and neck (SCCHN). Read More ›

Incorporating Caregivers Improves Physical Activity and Quality of Life in Patients With Cancer

By Alice Goodman

Best Practices

TON - June 2013, Vol 6, No 5 — July 10, 2013

Real-life experience translated into a research interest for Fedricker Barber, RN, ANP, AOCNP, of the MD Anderson Cancer Center in Houston, Texas. Read More ›

Addressing Spiritual Concerns

By Alice Goodman

Supportive Care

TON - June 2013, Vol 6, No 5 — July 10, 2013

Evidence suggests that cancer patients commonly experience spiritual pain or distress but believe that their spiritual needs are not being adequately addressed by healthcare providers. Read More ›

AUA Revises Its Guidelines for PSA-Based Prostate Cancer Screening

By Charles Bankhead

Genitourinary Cancers

TON - June 2013, Vol 6, No 5 — July 10, 2013

Prostate cancer screening with prostate-specific antigen (PSA) tests should focus on men aged 55 to 69 years, the group that is the most likely to benefit from screening. Read More ›

Intermittent Vemurafenib May Overcome Resistance

Skin Cancer

TON - June 2013, Vol 6, No 5 — July 10, 2013

Vemurafenib is a relatively new effective option for the treatment of melanoma, but most patients who respond will develop resistance. Read More ›